A NEW EXPERIMENTAL AND CLINICAL APPROACH OF COMBINING USAGE OF HIGHLY ACTIVE TUMOR-INFILTRATING LYMPHOCYTES AND HIGHLY SENSITIVE ANTITUMOR DRUGS FOR THE ADVANCED MALIGNANT TUMOR

In recent years, tumor-nfiltrating lymphocytes (TILs) have been reported to be effective for tumors in experimental and clinical research. In order to increase the therapeutical effect, we modified some steps of Rosenberg’s approach a. cold digestion with collagenase at 4C for 24 hours; b. sedimenta...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	中华医学杂志：英文版 1994 (11), p.5-9
1. Verfasser:	李彪如童善庆张希衡陆静顾琴龙陆德源
Format:	Artikel
Sprache:	eng
Schlagworte:	antitumor cultivation cytotoxicity digestion elimination instead potent Rosenberg sedimentation steps
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	9
container_issue	11
container_start_page	5
container_title	中华医学杂志：英文版
container_volume
creator	李彪如童善庆张希衡陆静顾琴龙陆德源
description	In recent years, tumor-nfiltrating lymphocytes (TILs) have been reported to be effective for tumors in experimental and clinical research. In order to increase the therapeutical effect, we modified some steps of Rosenberg’s approach a. cold digestion with collagenase at 4C for 24 hours; b. sedimentation instead of centrifugation; c. elimination of tumor cells before the cultivation procedure. Compared with the original approach, the proliferation, activity and cytotoxicity of TILs obtained by the modified procedure were much improved. TILs’ expansion-old was greater than that with the original approach. Cytotoxicity against rumor cells was more potent. Increased TILs’ subsets were CD3 and CD8 cells. Meanwhile, we took tumor cells from tumor tissues to test their in vitro chemosensitivities to different drugs in order to select highly sensitive antitumor drugs for treatment of cases with advanced tumors. According to the design of using highly active TILs and highly sensitive drugs (H & H therapy), preli
format	Article
fullrecord	<record><control><sourceid>chongqing</sourceid><recordid>TN_cdi_chongqing_primary_1005052292</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>1005052292</cqvip_id><sourcerecordid>1005052292</sourcerecordid><originalsourceid>FETCH-chongqing_primary_10050522923</originalsourceid><addsrcrecordid>eNqNjEFOwzAQRS1EJQLlDiOxjuS6tVGWxnFsS7YT2U4hq6pCUIqgQLPiWNyQJPQArObP0_v_DGWErkhO2WpxjjK8ZCxnRVFcoMu-f8WYUHrLMvTDwct7kA-NDMZJn7gF7ksQ1ngjxqdpQs2FhroCUbu7AXsFbeRKjkgbpW0HXCSzlpBaV4fc-MrYFHgaTdu5RteiSzJOw6dClD6aqcN9MlMPytCqCNWQkh54ueZeyBIct0b5Qfubn6PZ8_atf7o-3St0U8kkdP748nHYfe0Pu83ncf--PX5vFhhTTAkpyPJ_1i_h0VKL</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A NEW EXPERIMENTAL AND CLINICAL APPROACH OF COMBINING USAGE OF HIGHLY ACTIVE TUMOR-INFILTRATING LYMPHOCYTES AND HIGHLY SENSITIVE ANTITUMOR DRUGS FOR THE ADVANCED MALIGNANT TUMOR</title><source>Alma/SFX Local Collection</source><creator>李彪如童善庆张希衡陆静顾琴龙陆德源</creator><creatorcontrib>李彪如童善庆张希衡陆静顾琴龙陆德源</creatorcontrib><description>In recent years, tumor-nfiltrating lymphocytes (TILs) have been reported to be effective for tumors in experimental and clinical research. In order to increase the therapeutical effect, we modified some steps of Rosenberg’s approach a. cold digestion with collagenase at 4C for 24 hours; b. sedimentation instead of centrifugation; c. elimination of tumor cells before the cultivation procedure. Compared with the original approach, the proliferation, activity and cytotoxicity of TILs obtained by the modified procedure were much improved. TILs’ expansion-old was greater than that with the original approach. Cytotoxicity against rumor cells was more potent. Increased TILs’ subsets were CD3 and CD8 cells. Meanwhile, we took tumor cells from tumor tissues to test their in vitro chemosensitivities to different drugs in order to select highly sensitive antitumor drugs for treatment of cases with advanced tumors. According to the design of using highly active TILs and highly sensitive drugs (H &amp; H therapy), preli</description><identifier>ISSN: 0366-6999</identifier><identifier>EISSN: 2542-5641</identifier><language>eng</language><subject>antitumor ; cultivation ; cytotoxicity ; digestion ; elimination ; instead ; potent ; Rosenberg ; sedimentation ; steps</subject><ispartof>中华医学杂志：英文版, 1994 (11), p.5-9</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85656X/85656X.jpg</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids></links><search><creatorcontrib>李彪如童善庆张希衡陆静顾琴龙陆德源</creatorcontrib><title>A NEW EXPERIMENTAL AND CLINICAL APPROACH OF COMBINING USAGE OF HIGHLY ACTIVE TUMOR-INFILTRATING LYMPHOCYTES AND HIGHLY SENSITIVE ANTITUMOR DRUGS FOR THE ADVANCED MALIGNANT TUMOR</title><title>中华医学杂志：英文版</title><addtitle>Chinese Medical Journal</addtitle><description>In recent years, tumor-nfiltrating lymphocytes (TILs) have been reported to be effective for tumors in experimental and clinical research. In order to increase the therapeutical effect, we modified some steps of Rosenberg’s approach a. cold digestion with collagenase at 4C for 24 hours; b. sedimentation instead of centrifugation; c. elimination of tumor cells before the cultivation procedure. Compared with the original approach, the proliferation, activity and cytotoxicity of TILs obtained by the modified procedure were much improved. TILs’ expansion-old was greater than that with the original approach. Cytotoxicity against rumor cells was more potent. Increased TILs’ subsets were CD3 and CD8 cells. Meanwhile, we took tumor cells from tumor tissues to test their in vitro chemosensitivities to different drugs in order to select highly sensitive antitumor drugs for treatment of cases with advanced tumors. According to the design of using highly active TILs and highly sensitive drugs (H &amp; H therapy), preli</description><subject>antitumor</subject><subject>cultivation</subject><subject>cytotoxicity</subject><subject>digestion</subject><subject>elimination</subject><subject>instead</subject><subject>potent</subject><subject>Rosenberg</subject><subject>sedimentation</subject><subject>steps</subject><issn>0366-6999</issn><issn>2542-5641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNqNjEFOwzAQRS1EJQLlDiOxjuS6tVGWxnFsS7YT2U4hq6pCUIqgQLPiWNyQJPQArObP0_v_DGWErkhO2WpxjjK8ZCxnRVFcoMu-f8WYUHrLMvTDwct7kA-NDMZJn7gF7ksQ1ngjxqdpQs2FhroCUbu7AXsFbeRKjkgbpW0HXCSzlpBaV4fc-MrYFHgaTdu5RteiSzJOw6dClD6aqcN9MlMPytCqCNWQkh54ueZeyBIct0b5Qfubn6PZ8_atf7o-3St0U8kkdP748nHYfe0Pu83ncf--PX5vFhhTTAkpyPJ_1i_h0VKL</recordid><startdate>1994</startdate><enddate>1994</enddate><creator>李彪如童善庆张希衡陆静顾琴龙陆德源</creator><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope></search><sort><creationdate>1994</creationdate><title>A NEW EXPERIMENTAL AND CLINICAL APPROACH OF COMBINING USAGE OF HIGHLY ACTIVE TUMOR-INFILTRATING LYMPHOCYTES AND HIGHLY SENSITIVE ANTITUMOR DRUGS FOR THE ADVANCED MALIGNANT TUMOR</title><author>李彪如童善庆张希衡陆静顾琴龙陆德源</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-chongqing_primary_10050522923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>antitumor</topic><topic>cultivation</topic><topic>cytotoxicity</topic><topic>digestion</topic><topic>elimination</topic><topic>instead</topic><topic>potent</topic><topic>Rosenberg</topic><topic>sedimentation</topic><topic>steps</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>李彪如童善庆张希衡陆静顾琴龙陆德源</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><jtitle>中华医学杂志：英文版</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>李彪如童善庆张希衡陆静顾琴龙陆德源</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A NEW EXPERIMENTAL AND CLINICAL APPROACH OF COMBINING USAGE OF HIGHLY ACTIVE TUMOR-INFILTRATING LYMPHOCYTES AND HIGHLY SENSITIVE ANTITUMOR DRUGS FOR THE ADVANCED MALIGNANT TUMOR</atitle><jtitle>中华医学杂志：英文版</jtitle><addtitle>Chinese Medical Journal</addtitle><date>1994</date><risdate>1994</risdate><issue>11</issue><spage>5</spage><epage>9</epage><pages>5-9</pages><issn>0366-6999</issn><eissn>2542-5641</eissn><abstract>In recent years, tumor-nfiltrating lymphocytes (TILs) have been reported to be effective for tumors in experimental and clinical research. In order to increase the therapeutical effect, we modified some steps of Rosenberg’s approach a. cold digestion with collagenase at 4C for 24 hours; b. sedimentation instead of centrifugation; c. elimination of tumor cells before the cultivation procedure. Compared with the original approach, the proliferation, activity and cytotoxicity of TILs obtained by the modified procedure were much improved. TILs’ expansion-old was greater than that with the original approach. Cytotoxicity against rumor cells was more potent. Increased TILs’ subsets were CD3 and CD8 cells. Meanwhile, we took tumor cells from tumor tissues to test their in vitro chemosensitivities to different drugs in order to select highly sensitive antitumor drugs for treatment of cases with advanced tumors. According to the design of using highly active TILs and highly sensitive drugs (H &amp; H therapy), preli</abstract></addata></record>
fulltext	fulltext
identifier	ISSN: 0366-6999
ispartof	中华医学杂志：英文版, 1994 (11), p.5-9
issn	0366-6999 2542-5641
language	eng
recordid	cdi_chongqing_primary_1005052292
source	Alma/SFX Local Collection
subjects	antitumor cultivation cytotoxicity digestion elimination instead potent Rosenberg sedimentation steps
title	A NEW EXPERIMENTAL AND CLINICAL APPROACH OF COMBINING USAGE OF HIGHLY ACTIVE TUMOR-INFILTRATING LYMPHOCYTES AND HIGHLY SENSITIVE ANTITUMOR DRUGS FOR THE ADVANCED MALIGNANT TUMOR
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T07%3A42%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-chongqing&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20NEW%20EXPERIMENTAL%20AND%20CLINICAL%20APPROACH%20OF%20COMBINING%20USAGE%20OF%20HIGHLY%20ACTIVE%20TUMOR-INFILTRATING%20LYMPHOCYTES%20AND%20HIGHLY%20SENSITIVE%20ANTITUMOR%20DRUGS%20FOR%20THE%20ADVANCED%20MALIGNANT%20TUMOR&rft.jtitle=%E4%B8%AD%E5%8D%8E%E5%8C%BB%E5%AD%A6%E6%9D%82%E5%BF%97%EF%BC%9A%E8%8B%B1%E6%96%87%E7%89%88&rft.au=%E6%9D%8E%E5%BD%AA%E5%A6%82%20%E7%AB%A5%E5%96%84%E5%BA%86%20%E5%BC%A0%E5%B8%8C%E8%A1%A1%20%E9%99%86%E9%9D%99%20%E9%A1%BE%E7%90%B4%E9%BE%99%20%E9%99%86%E5%BE%B7%E6%BA%90&rft.date=1994&rft.issue=11&rft.spage=5&rft.epage=9&rft.pages=5-9&rft.issn=0366-6999&rft.eissn=2542-5641&rft_id=info:doi/&rft_dat=%3Cchongqing%3E1005052292%3C/chongqing%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_cqvip_id=1005052292&rfr_iscdi=true